HENNION & WALSH ASSET MANAGEMENT, INC. – Revance Therapeutics, Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$2.27M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.35% | -4.76K shares | 1.04M | $27 | 84.25K |
| Q2 2022 | share | Decrease | -4.44% | -4.13K shares | -587K | $13.82 | 89.02K |
| Q1 2022 | share | Decrease | -3.47% | -3.35K shares | 242K | $19.5 | 93.15K |
| Q4 2021 | share | Decrease | -8.38% | -8.82K shares | -1.36M | $16.49 | 96.50K |
| Q3 2021 | share | Decrease | -2.16% | -2.32K shares | -256K | $27.86 | 105.33K |
| Q2 2021 | share | Increase | +16.02% | 14.86K shares | 597K | $29.64 | 107.65K |
| Q1 2021 | share | Increase | 0.00% | 92.79K shares | 2.59M | $27.95 | 92.79K |